The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

RSV is a leading cause of hospitalization among infants in the United States. (Scripps News) Trump backers call for Walmart boycott amid furor over ‘No Kings Day’ ad Shark Tank's Kevin O'Leary warns ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ...

Staff who provide data to the vaccine panel have been pushed aside, according to health officials, raising doubts about the ...

BURLINGTON, ON / ACCESS Newswire / June 13, 2025 / Safe 'N' Sound Environmental Services Ltd., a Burlington-based environmental remediation firm, has been recognized with the 2025 Consumer Choice ...

After firing the former members of ACIP earlier this week, Kennedy has appointed eight new members to the vaccine advisory board – including some vaccine skeptics.

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

Newco Elkedonia SAS has raised €11 million (US$12.7 million) in a seed round, which will fund it to take a potentially first-in-class ELK-1 inhibitor into the clinic in the treatment of refractory ...